Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Research

Recordati Industria Chimica e Farmaceutica S.p.A., alongside its global subsidiaries, is actively involved in the discovery, formulation, production, promotion, and distribution of pharmaceutical products worldwide. Its extensive portfolio addresses a broad spectrum of medical needs, encompassing treatments for cardiovascular conditions, dermatological issues, urological problems, and infections. The firm also develops solutions for central nervous system disorders, gastrointestinal health, women's health (gynecology and obstetrics), musculoskeletal ailments, and pain relief. Additionally, Recordati provides a range of over-the-counter medications, allergy treatments, endocrine therapies, respiratory drugs, oncology products, and remedies for ear, nose, and throat conditions. Beyond prescription drugs, the company offers nutrition-related items, cosmetics, dietary supplements, medical devices, generic drugs, antipyretics, and cold preparations. Moreover, the company is dedicated to offering therapies for rare diseases and produces essential pharmaceutical chemicals, including active pharmaceutical ingredients (APIs), intermediate compounds, and undertaking chemical syntheses. Established in Milan, Italy, in 1926, Recordati Industria Chimica e Farmaceutica S.p.A. currently operates as a subsidiary of Rossini S.à R.L.

Open Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.